emoflon® is a triple action ointment with medical device status, which protects the anal mucosa, relieves the itchy and inflamed anal mucosa and promotes skin regeneration and wound healing SERVIER MALAYSIA has launched emoflon®, an ointment for the treatment of symptoms associated with hemorrhoidal disease and its complications (eg, eczema, anal fissure), to meet patients’ […]
Abby L. Allen, RN, NP: Update on Biologics for Atopic Dermatitis What are some of the challenges and triumphs in using biologics for atopic dermatitis? Abby L. Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting. Promising Results for Roflumilast Cream 0.15% From the INTEGUMENT Phase […]
Absci Corporation, a leader in generative artificial intelligence (AI) drug creation, and Almirall, a global biopharmaceutical company specializing in medical dermatology, have announced1 a strategic partnership aimed at revolutionizing the landscape of dermatological therapeutics. The collaboration seeks to incorporate the power of AI in developing and commercializing treatments for chronic and debilitating skin diseases. The […]